132 related articles for article (PubMed ID: 7900272)
1. Effects of naloxone on pulsatile luteinizing hormone in experimental hyperprolactinemia.
Lafuente A; Marco J; Moreno ML; Esquifino AI
Vet Hum Toxicol; 1994 Dec; 36(6):529-32. PubMed ID: 7900272
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the pulsatile prolactin secretory pattern: effects of hyperprolactinemia.
Lafuente A; Marco J; Esquifino AI
Vet Hum Toxicol; 1994 Dec; 36(6):524-8. PubMed ID: 7900271
[TBL] [Abstract][Full Text] [Related]
3. Effects of hyperprolactinemia on prolactin and LH pulsatile pattern in female rats.
Lafuente A; Marcó J; Esquifino AI
Rev Esp Fisiol; 1992 Dec; 48(4):291-6. PubMed ID: 1302899
[TBL] [Abstract][Full Text] [Related]
4. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
Tresguerres JA; Esquifino AI
Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
[TBL] [Abstract][Full Text] [Related]
5. Possible changes in the regulatory mechanisms of pulsatile luteinizing hormone secretion in adult pituitary-grafted female rats.
Lafuente A; Marcó J; Esquifino AI
Proc Soc Exp Biol Med; 1995 Jun; 209(2):163-9. PubMed ID: 7770467
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine modifies the pulsatile secretory patterns of prolactin and luteinizing hormone in normal and pituitary-grafted female rats.
Esquifino AI; Marcó J; Lafuente A
Neuroendocrinology; 1994 Dec; 60(6):581-8. PubMed ID: 7700501
[TBL] [Abstract][Full Text] [Related]
7. Effects of cyclosporine on circulating levels of prolactin, LH, FSH, TSH and GH in chronic hyperprolactinemic male rats.
Lafuente A; Alvarez-Demanuel E; Blanco A; García-Bonacho M; Esquifino AI
Rev Esp Fisiol; 1996 Sep; 52(3):161-6. PubMed ID: 8974151
[TBL] [Abstract][Full Text] [Related]
8. Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat.
Fox SR; Hoefer MT; Bartke A; Smith MS
Neuroendocrinology; 1987 Oct; 46(4):350-9. PubMed ID: 2823160
[TBL] [Abstract][Full Text] [Related]
9. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
10. Altered sensitivity to an opiate antagonist, naloxone, in hyperprolactinemic male rats.
Sweeney CA; Morgan WW; Smith MS; Bartke A
Neuroendocrinology; 1985 Jul; 41(1):1-6. PubMed ID: 3895021
[TBL] [Abstract][Full Text] [Related]
11. Effects of cyclosporin treatment on prolactin pulsatility in chronic hyperprolactinemic male rats.
Lafuente A; Salgado A; García-Bonacho M; Esquifino AI
J Neuroimmunol; 1996 Mar; 65(1):41-7. PubMed ID: 8642062
[TBL] [Abstract][Full Text] [Related]
12. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
Cicero TJ; Nock B; O'Connor L
J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
[TBL] [Abstract][Full Text] [Related]
13. Effects of luteinizing hormone-releasing hormone on pulsatile prolactin secretion in adult hyperprolactinemic female rats.
Lafuente A; Marco J; Esquifino A
Proc Soc Exp Biol Med; 1996 Mar; 211(3):251-6. PubMed ID: 8633105
[TBL] [Abstract][Full Text] [Related]
14. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator.
Sarkar DK; Yen SS
Endocrinology; 1985 May; 116(5):2080-4. PubMed ID: 3157564
[TBL] [Abstract][Full Text] [Related]
15. Effects of insulin on luteinizing hormone and prolactin secretion and calcium signaling in female rat pituitary cells.
Weiss JM; Polack S; Diedrich K; Ortmann O
Arch Gynecol Obstet; 2003 Nov; 269(1):45-50. PubMed ID: 12827388
[TBL] [Abstract][Full Text] [Related]
16. Atrazine inhibits pulsatile luteinizing hormone release without altering pituitary sensitivity to a gonadotropin-releasing hormone receptor agonist in female Wistar rats.
Foradori CD; Hinds LR; Hanneman WH; Legare ME; Clay CM; Handa RJ
Biol Reprod; 2009 Jul; 81(1):40-5. PubMed ID: 19299313
[TBL] [Abstract][Full Text] [Related]
17. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
Seki K; Kato K; Shima K
J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
[TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinemia alters the frequency and amplitude of pulsatile luteinizing hormone secretion in the ovariectomized rat.
Cohen-Becker IR; Selmanoff M; Wise PM
Neuroendocrinology; 1986; 42(4):328-33. PubMed ID: 3515222
[TBL] [Abstract][Full Text] [Related]
19. Possible interactions of cyclosporine and hyperprolactinemia modulating the episodic secretion of prolactin.
Esquifino AI; Gonzalez ME; Lafuente A
Proc Soc Exp Biol Med; 1996 Nov; 213(2):206-11. PubMed ID: 8931666
[TBL] [Abstract][Full Text] [Related]
20. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat.
Gruenewald DA; Naai MA; Marck BT; Matsumoto AM
J Androl; 2000; 21(1):72-84. PubMed ID: 10670522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
